(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all relevant information.
|
It was reported that resistance was met during advancement of the nav 6 embolic protection device (epd) through the mildly calcified, moderately tortuous, 80% stenosed, de novo, mid carotid artery, resulting in a dissection from the tip of the guide wire.A spasm was noted at the site of the dissection and nitroglycerin was administered.The device was removed from the anatomy.A different epd was placed and an abbott stent was implanted to cover the dissection and complete the procedure.There was no reported adverse patient sequela or a clinically significant delay in the procedure.No additional information was provided.
|
(b)(4).Evaluation summary: visual inspection was performed on the returned device.The reported difficulty advancing was not able to be confirmed as it was based on case circumstances.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no similar incidents.Dissection and vasospasm are listed in the emboshield nav 6 instruction for use (ifu) as adverse events potentially associated with carotid stents and embolic protection systems.The failure to advance and subsequent patient effects were likely due to anatomical conditions and there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
|